Suchergebnisse - "Cook, Gordon"

PubPharm (409)

1

Genomic Classification and Individualized Prognosis in Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Maura, F. | Rajanna, A. | Ziccheddu, B. | +34

2

Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma : results from the NCRI Myeloma X (intensive) trial

enthalten in: Bone marrow transplantation | 2024

von de Tute, R. | Cook, G. | Cairns, D. | +12

3

Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination

enthalten in: European journal of haematology | 2024

von Twumasi, C. | Moore, S. | Sadler, R. | +20

4

Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma

enthalten in: Haematologica | 2024

von Agarwal, G. | Moore, S. | Sadler, R. | +21

5

Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination

enthalten in: European Journal of Haematology | 2024

von Twumasi, C. | Moore, S. | Sadler, R. | +20

6

Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study

enthalten in: Insights into imaging | 2023

von Keaveney, S. | Dragan, A. | Rata, M. | +25

7

A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction

enthalten in: EJHaem | 2023

von Chandler, T. | Parrish, C. | Karakantza, M. | +4

8

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Kaiser, M. | Hall, A. | Walker, K. | +17

9

Cytokine receptor IL27RA is an NF-κB-responsive gene involved in CD38 upregulation in multiple myeloma

enthalten in: Blood advances | 2023

von Brownlie, R. | Kennedy, R. | Wilson, E. | +18

10

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

enthalten in: EClinicalMedicine | 2023

von Jones, J. | Cairns, D. | Menzies, T. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[41]